Last edition
News about "generic medicines"
India-UK FTA to Boost Pharma Exports Beyond USD 981 Million in FY2026-27: Pharmexcil
India-UK FTA is expected to boost India's pharmaceutical exports to the UK beyond USD 981 million in FY2026-27, building on strong export growth, according to Pharmexcil.
Generic Medicines | 16/07/2026 | By News Bureau | 106
Health Minister Nadda Launches National Drug Registry
Union Health Minister JP Nadda has launched the National Drug Registry to standardise medicine information, enhancing transparency, trust, and seamless access to drug data across India.
Generic Medicines | 01/07/2026 | By News Bureau
Commerce Minister Invites Global Pharma Companies to Partner India's Growth Story
Union Commerce Minister Piyush Goyal has invited global pharmaceutical companies to partner with India’s rapidly growing healthcare sector, highlighting the country’s 7.7 percent economic growth and its transition from a generics-led market to an innovation-driven pharmaceutical hub.
Generic Medicines | 09/06/2026 | By News Bureau | 120
Aspire Pharma acquires Charlwood Pharma
Aspire Pharma, a UK-based specialty generics pharma business, has announced the acquisition of Charlwood Pharma Ltd — a privately-owned company specialising in the research and development of niche generic medicines. The deal marks the culmination of a successful multi-year collaboration between the two organisations.
Generic Medicines | 21/10/2025 | By Dineshwori | 443
Informa Markets Announces 17th Edition of CPHI and PMEC India Expo in November
The CPHI & PMEC India Expo 2024 promises to be a transformative event for the pharmaceutical sector, bringing together over 50,000 industry professionals and 2,000 exhibitors, who will present more than 10,000 innovative products.
Generic Medicines | 21/10/2024 | By Aishwarya | 725
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy